Clinical Trials
81 trialsROXI-CAT-I
Regeneron Pharmaceuticals
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
MAGNOLIA
Anthos Therapeutics, Inc.
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
SUPERCAT
Centre Hospitalier Universitaire, Amiens
ROXI-CAT-II
Regeneron Pharmaceuticals
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
The First Hospital of Jilin University
ASTER
Anthos Therapeutics, Inc.
ACE-HIGH
Ottawa Hospital Research Institute
CATIQ P3
Quercis Pharma AG
TALENTOP
Fudan University
Comparison of Vascular Catheter-Related Thrombosis and Risk Factors After Oncologic and Non-Oncologic Major Surgery
Mersin University
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
Chang Gung Memorial Hospital
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
Sixth Affiliated Hospital, Sun Yat-sen University
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Mayo Clinic
ONCO PE
Kyoto University, Graduate School of Medicine
PREPOSTEROUS
Helsinki University Central Hospital
MVTEP2/SOME2
University Hospital, Brest
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Mount Sinai Hospital, Canada
CAPE
University Hospital, Brest
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Sixth Affiliated Hospital, Sun Yat-sen University
Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
COSIMO
Bayer
ONCO DVT
Kyoto University, Graduate School of Medicine
CANVAS
Alliance Foundation Trials, LLC.
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Nordsjaellands Hospital
The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
The University of Texas Medical Branch, Galveston
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute
Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism
Tongji Hospital
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
ONCOTHROMB
Hospital General Universitario Gregorio Marañon
Ésquilo
Hospital do Servidor Publico Estadual
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
University of Utah
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
China-Japan Friendship Hospital
D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs
G. d'Annunzio University
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients
Hellenic Society of Medical Oncology
3DUrologia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery
Istanbul Medeniyet University
DVT
University of Texas Southwestern Medical Center
PREVENTER
Johns Hopkins University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
DVT
Beni-Suef University
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
LiuZhou People's Hospital
PREDICARE
LEO Pharma
Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer
G. d'Annunzio University
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong